Hui Zhao

LiveDNA ID: 86.35841

7 Publications

0 Editorial Roles

0 Projects

Education

Academic Background

M.B.B.S Northwest University, China Life Science and Medicine | Completed: 2020

Publications (7)

Selected Scholarly Contributions

Biochanin A suppresses ferroptosis after traumatic brain injury via the Nrf2/HO-1 signaling pathway

Yuehuan Hu, Mingxia Zhang, Hui Zhao, Yao Ruan, Tian Liu

Scientific Reports | Journal Article

10.1038/s41598-026-74944-z

2026

Poricoic acid A attenuates renal fibrosis by inhibiting endoplasmic reticulum stress-mediated apoptosis

Hui Zhao, Tian Liu, Chang-E Yang, Yue-Huan Hu, Yan Niu, Sheng-Ping Lei, Lin Chen, Ming-Xia Zhang

Brazilian Journal of Medical and Biological Research | Journal Article

10.1590/1414-431x2024e14249

2024

Natural products against renin-angiotensin system for antifibrosis therapy.

Yang, T., Y.Y. Chen, J.R. Liu, H. Zhao, N.D. Vaziri, Y. Guo and Y.Y. Zhao,

Eur. J. Med. Chem., | Journal Article

10.1016/j.ejmech.2019.06.091

Hui Zhao

2019

microRNAs in chronic kidney disease.

Zhao, H., S.X. Ma, Y.Q. Shang, H.Q. Zhang and W. Su,

Clin. Chim. Acta, | Journal Article

10.1016/j.cca.2019.01.008

Hui Zhao

2019

Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis.

Wang, M., D.Q. Chen, L. Chen, G. Cao and H. Zhao et al.,

Br. J. Pharmacol., | Journal Article

10.1111/bph.14333

Hui Zhao

2018

Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.

Chen, L., T. Yang, D.W. Lu, H. Zhao and Y.L. Feng et al.,

Biomed. Pharmacother., | Journal Article

10.1016/j.biopha.2018.02.090

Hui Zhao

2018

Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.

Wang, M., D.Q. Chen, M.C. Wang, H. Chen and L. Chen et al.,

Phytomedicine, | Journal Article

10.1016/j.phymed.2017.10.008

Hui Zhao

2017